Analysts See More Upside For Sarepta Therapeutics By: Benzinga via Benzinga May 20, 2015 at 16:48 PM EDT Sarepta Therapeutics Inc(NASDAQ: SRPT) gained more than 60 percent Wednesday on news that it expects to complete an approval ... Read More >> Related Stocks: Sarepta Therapeutics